Holdings  > Holding Rationales  > MNKD: Interesting Biotech Pros...

Holding: MNKD

drxeno [127] Star!Star!

Start tracking!

You are not tracking drxeno.

Symbol Sector Return Exposure Trades Last Trade Status
MNKD Biotechnology 27.42% 
Long
4  04-Nov-08  Currently Holding
<< Previous Post     Next Post >>

20-Jul-08

MNKD: Interesting Biotech Prospect

Holding Rationale for MNKD.

Mannkind has a great drug in development that really has been beaten down due to rivals' failures...yet their failures are due to different formulations and MOA's than Mannkind's Technosphere platform.  I agree.  I bought in and here's hoping that the market and FDA realize those differences and I was able to buy in on bad rumors!

http://www.fool.com/investing/small-cap/2008/05/06/mannkind-moves-ahead.aspx

Tagged Stocks: MNKD

 

Posted at 19:36 in Holding Rationales  |   Permalink  |   Comments ()     |  Top

AddThis Social Bookmark Button
 
 
 

Credibility in MNKD

drxeno

MNKD Long
Rank 2/17
Return 27.42% at 2008-11-20
Rank 2/17
Trades 4
Followers 14
 

Categories

External Blog (52)

Holding Rationales (152)

Investment Knowledge (1)

Market Report (4)

Holding Tags

AAPL (3)

ACEL (2)

AKAM (3)

ARIA (4)

ARNA (2)

ASPV (4)

CLDA (1)

CLVLY (2)

CVM (4)

CVTX (4)

EEM (10)

EEV (4)

ELN (1)

ENER (4)

EPP (1)

EWA (3)

EWG (3)

EWJ (2)

EWZ (11)

EXEL (5)

FUSEX (1)

GILD (4)

GMFX (1)

GOOG (2)

GTXI (4)

IEV (1)

IFN (6)

ILF (13)

ISIS (4)

IXG (2)

IYG (1)

IYM (2)

JSDA (3)

LVMUY (2)

MEDX (4)

MNKD (1)

MO (7)

MS (1)

MYGN (1)

NVLT (1)

OXM (2)

PGNX (2)

PM (2)

RAIL (1)

RMBS (10)

SPY (2)

SSO (5)

SU (7)

TKO (4)

URBN (2)

USO (1)

VDC (3)

VDE (2)

VLCM (1)

XLU (2)

Other Stock Tags

BIIB (1)

CVD (1)

DGX (1)

KP:000660 (1)

KP:000830 (1)

MU (1)

 

Archives

Nov 2008 (12)

Sep 2008 (11)

Aug 2008 (6)

Jul 2008 (18)

Jun 2008 (5)

May 2008 (8)

Apr 2008 (7)

Mar 2008 (22)

Feb 2008 (11)

Jan 2008 (15)

Nov 2007 (17)

Oct 2007 (4)